U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488897) titled 'RIG 101 Trial in Healthy Adults and Adults With Asthma' on Feb. 26.
Brief Summary: Nested Phase 1-2 Trial of RIG-101 in Healthy and Asthmatic Participants Assessing Safety, Tolerability and Viral Challenge Efficacy
Study Start Date: Feb. 09
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Asthma Exacerbation
Safety and Efficacy
Intervention:
DRUG: RIG-101
Single, and repeat escalating intranasal administrations of RIG-101
OTHER: Placebo
Single and repeat Intranasal administrations
Recruitment Status: RECRUITING
Sponsor: RIGImmune Inc.
Published by HT Digital Content Services with permission from Health D...